Florence Releases 2022 State of Clinical Trial Operations Technology Report
Florence Healthcare has released its annual State of Clinical Trial Operations Technology Report. More than 190 clinical operations leaders from across the drug development lifecycle contributed to this year’s report, revealing their thoughts and recommendations for the next year of technology transformation in the industry.
Key findings from the survey include:
- 61% of all respondents believe managing clinical trial operations in one platform is extremely important, while 66% of sponsors say eliminating paper from their operations is a top reason for investing in technology.
- 89% of sponsors indicate they use elements of decentralized clinical trials (DCT) in their trials, with hospitals and health systems the highest adopters of DCT elements, at 92%.
- 89% of sites intend to have an electronic investigator site file (eISF) in place by the end of 2022, and 88% expect to use eConsent for patient-informed consent.
- 72% of sites make technology decisions based on how much repetitive work a new technology eliminates.
Access additional information and the full report here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
